Ken Morita

Kushiro, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Short Pretransplant Dialysis Periods are Clinically Acceptable Without Compromising Kidney Transplant Outcomes: A Japanese Multicenter Study.

Short Pretransplant Dialysis Periods are Clinically Acceptable Without Compromising Kidney Transplant Outcomes: A Japanese Multicenter Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: February 17, 2026

Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional Study.

Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: October 20, 2025

Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan.

Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan.

Journal: Cancer science

Published: July 28, 2025

A Case of Testicular Cancer with Solitary Iliac Bone Metastasis

A Case of Testicular Cancer with Solitary Iliac Bone Metastasis

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: October 05, 2023

Impact of postoperative complications on long-term survival in bladder cancer patients.

Impact of postoperative complications on long-term survival in bladder cancer patients.

Journal: Japanese journal of clinical oncology

Published: May 02, 2023

Validation of the Japanese version of the Body Image Scale for bladder cancer patients.

Validation of the Japanese version of the Body Image Scale for bladder cancer patients.

Journal: Scientific reports

Published: April 20, 2022

Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors in patients with renal cell carcinoma.

Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors in patients with renal cell carcinoma.

Journal: Urologic oncology

Published: June 10, 2021

Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities.

Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities.

Journal: Urologic oncology

Published: January 21, 2021

Comparison of Health-Related Quality of Life Between Japanese and American Patients with Bladder Cancer as Measured by a Newly Developed Japanese Version of the Bladder Cancer Index.

Comparison of Health-Related Quality of Life Between Japanese and American Patients with Bladder Cancer as Measured by a Newly Developed Japanese Version of the Bladder Cancer Index.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: July 17, 2020

Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index.

Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index.

Journal: International journal of clinical oncology

Published: June 08, 2020

Development and validation of a porcine organ model for training in essential laparoscopic surgical skills.

Development and validation of a porcine organ model for training in essential laparoscopic surgical skills.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 26, 2020

Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.

Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.

Journal: Cancer science

Published: March 17, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026